A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Enrolling by invitation · Phase 3 · NCT04976322
Conditions: Systemic Lupus Erythematosus
At a glance
- Research payments reported, 2025
- $442,161
- U.S. investigators named
- 23
- Sites paid
- 23
- Planned or actual enrollment
- 760
About the trial
- Sponsor
- UCB Biopharma SRL
- Tested
- Dapirolizumab pegol (drug)
- Dates
- Started 2021-07-27; completion 2030-08-07
- Results posted
- Not yet
The purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
From ClinicalTrials.gov, last updated 2026-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
UCB SA reported $442,161 in research payments for this study in 2025 (31 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jose E. Rubio Mosquera, M.D Rheumatology · Birmingham, AL
- Swati S. Bharadwaj, MD, MPH Rheumatology · Phoenix, AZ
- Jeffrey B. Loomer, MD Rheumatology · Tucson, AZ
- Gerald Y. Ho, M.D. Rheumatology · La Palma, CA
- Kenneth C. Kalunian, MD Rheumatology · San Diego, CA
- Daniel J. Wallace, MD Rheumatology · Beverly Hills, CA
- Michael R. Bubb, MD Rheumatology · Gainesville, FL
- Vipul M. Joshi, MD Specialist · Brandon, FL
- Lon D. Lynn, D.O. Family Medicine · Tampa, FL
- Jose C. Pinero, M.D. Hospitalist · Miami, FL
- Jorge L. Posada, MD Nephrology (Kidney) · Coral Gables, FL
- Guillermo J. Valenzuela, MD Specialist · Plantation, FL
- Sung S. Lim, M.D., M.P.H. Rheumatology · Atlanta, GA
- Kishorkumar A. Desai, M.D. Rheumatology · Hopkinsville, KY
- Enrique A. Mendez, M.D. Rheumatology · Lake Charles, LA
- Mary P. Howell, MD Internal Medicine · Hagerstown, MD
- Ilyes Benchaala, MD Rheumatology · Detroit, MI
- Jane H. Box, MD Rheumatology · Charlotte, NC
- Anca Askanase, MD Rheumatology · New York, NY
- Ahuva Cices, MD Dermatology · New York, NY
- Eyal Kedar, M.D. Rheumatology · Canton, NY
- Nancy J. Olsen, MD Rheumatology · Hershey, PA
- Jacob Aelion, M.D. Specialist · Jackson, TN
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Arkansas Children's Hospital $66,112
- Djl Clinical Research PLLC $54,289
- University of Florida $49,232
- Accurate Clinical Research Inc $40,937
- University of Alabama Hospital, AL $38,271
- Western Ky Rheumatology PLLC $31,084
- Iris Research and Development LLC $26,993
- Wallace Rheumatic Study Center LLC $25,939
- Emory University Hospital, GA $25,425
- Arizona Arthritis and Rheumatology Research $14,944
- Wayne State University $14,205
- West Tennessee Research Institute $13,941
- Professional Research Center Inc $8,465
- Pennsylvania State University College of Medicine $5,800
- Vipul Joshi MD PA $5,579
- University of California San Diego Jacobs Medical Center $5,000
- Pediatric Neurology PA $4,300
- Advanced Medical Research $4,207
- Clinical Research of West Florida Inc $3,700
- St Lawrence Health System $1,850
- Klein & Associates MD PA $858
- Professional Research Center $536
- Emory University $495
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.